Karen L Tubridy Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karen L Tubridy.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karen L Tubridy. Karen L Tubridy is a Chief Development Officer in Eleven Biotherapeutics, Inc. ($EBIO) and a SVP, Chief Development Officer in Akebia Therapeutics, Inc. ($AKBA).

Address: C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE 02142 MA

Companies in which Karen L Tubridy is an Insider

Akebia Therapeutics, Inc.

Trading Symbol: AKBA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L Tubridy: SVP, Chief Development Officer
Holdings: 88,133 shares
Current Value: $870,754
Latest Transaction: Mar 02 2020
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sesen Bio, Inc.

Trading Symbol: SESN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L Tubridy: Chief Development Officer
Holdings: 32,753 shares
Current Value: $76,642
Latest Transaction: Jul 12 2016
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Karen L Tubridy

Sentiment: All, AKBA, SESN

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 02 2020AKBAAkebia Therapeutic ...Tubridy Karen LSVP, Chief Developm ...Option ExerciseA8.8785,000753,95085,000
Mar 02 2020AKBAAkebia Therapeutic ...Tubridy Karen LSVP, Chief Developm ...SellS8.703,45430,05084,67988.1 K to 84.7 K (-3.92 %)
Mar 02 2020AKBAAkebia Therapeutic ...Tubridy Karen LSVP, Chief Developm ...GrantA0.0030,000088,13358.1 K to 88.1 K (+51.61 %)
Apr 12 2019AKBAAkebia Therapeutic ...Tubridy Karen LSVP, Chief Developm ...SellD7.706,07546,77855,32461.4 K to 55.3 K (-9.89 %)
Dec 13 2018AKBAAkebia Therapeutic ...Tubridy Karen LSVP, Chief Developm ...Payment of ExerciseF8.9411,928106,63630,22942.2 K to 30.2 K (-28.29 %)
Mar 02 2018AKBAAkebia Therapeutic ...Tubridy Karen LSVP, Chief Developm ...Option ExerciseA14.3025,000357,50025,000
Mar 02 2018AKBAAkebia Therapeutic ...Tubridy Karen LSVP, Chief Developm ...GrantA0.0017,500041,51824 K to 41.5 K (+72.86 %)

View all Karen L Tubridy insider transactions.